Abstract
All screening programmes do harm; some also do good. The responsibility of the policy-maker is to decide which programmes do more good than harm at reasonable cost and then introduce them, once they are confident that the screening programme could and will reach the standard of quality required for success. The ratio of benefit to harm is not, however, constant and this relationship demonstrates a shifting balance.
Cite
CITATION STYLE
APA
Gray, J. A. M. (1998). Quality assurance in screening programmes. British Medical Bulletin. Royal Society of Medicine Press Ltd. https://doi.org/10.1093/oxfordjournals.bmb.a011742
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free